Skip to main content

Lantern Pharma Inc.

LTRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001763950

No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.

Members of Congress who traded LTRN

No member of Congress has reported a trade in Lantern Pharma Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.